AS
IONS icon

Altshuler Shaham’s Ionis Pharmaceuticals IONS Stock Holding History

Altshuler Shaham’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-695
Closed -$26.3K – 430
2022
Q4 		$26.3K Sell
695
-690
-50% -$29K ﹤0.01% 331
2022
Q3 		$61K Buy
1,385
+551
+66% +$23.2K ﹤0.01% 189
2022
Q2 		$31K Buy
+834
New +$31.4K ﹤0.01% 311
2019
Q3 		– Sell
-155
Closed -$10K – 487
2019
Q2 		$10K Buy
155
+42
+37% +$2.97K ﹤0.01% 295
2019
Q1 		$9K Buy
+113
New +$7.29K ﹤0.01% 247

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Altshuler Shaham's IONS Position: Q1 2023 in Review

Altshuler Shaham sold out of Ionis Pharmaceuticals (IONS) in Q1 2023, closing a stake of 695 shares — an estimated $26.3K sold.

Altshuler Shaham first reported a position in IONS in Q1 2019 and held it in 5 quarters. The position peaked at $61K in Q3 2022. 313 funds tracked by Wall St. Rank hold IONS as of Q1 2023.

  • Altshuler Shaham reported no remaining Ionis Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Altshuler Shaham sold 695 Ionis Pharmaceuticals shares in Q1 2023, an estimated $26.3K.
  • Altshuler Shaham first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Altshuler Shaham's Ionis Pharmaceuticals position peaked at $61K in Q3 2022.
  • 313 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.